clinical trial has been partially funded by the California Institute for Regenerative Medicine (CIRM).

?VAC2, a cancer immunotherapy of antigen-presenting dendritic cells currently in a Phase 1 clinical trial in non-small cell lung cancer. This clinical trial is being funded and conducted by Cancer Research UK, the world's largest independent cancer research charity.

?ANP1,

1.Previous
3.Next